Ocuphire Pharma Inc. buy Cantor Fitzgerald
Start price
14.08.23
/
50%
€3.83
Target price
14.08.24
€15.55
Performance (%)
-53.63%
Price
18.07.24
€1.78
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Ocuphire Pharma Inc. is performing very badly with a performance of -53.63%. This prediction currently runs until 14.08.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ocuphire Pharma Inc. | -1.443% | -1.443% |
iShares Core DAX® | -3.033% | -0.013% |
iShares Nasdaq 100 | -3.554% | -2.546% |
iShares Nikkei 225® | -3.938% | 2.183% |
iShares S&P 500 | -1.517% | -0.882% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $17.00 price target on the stock.
Ratings data for OCUP provided by MarketBeat